fda glp-1 compounded warning september 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our What Patients Need to Know

This combined approach supports long-term weight management by fostering healthier habits and coping strategies

Data Validation and Update Cycle: Outputs were subjected to variance testing against epidemiological data, production capacity announcements, and structured internal review prior to publication

How to access weight loss medications with Noom Our clinical team offers a wide array of medications to give the best treatment to those who qualify

Federal courts have already centralized GLP 1 vision loss claims in a multidistrict litigation proceeding in the Eastern District of Pennsylvania to coordinate pretrial proceedings

Lena wound up switching to Novo Nordisk's Wegovy, CVS Caremark's preferred obesity drug, and was relieved that it worked for her